Urs Karrer

4.6k total citations
48 papers, 3.0k citations indexed

About

Urs Karrer is a scholar working on Immunology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Urs Karrer has authored 48 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Immunology, 14 papers in Epidemiology and 11 papers in Infectious Diseases. Recurrent topics in Urs Karrer's work include Immune Cell Function and Interaction (17 papers), T-cell and B-cell Immunology (16 papers) and Immunotherapy and Immune Responses (11 papers). Urs Karrer is often cited by papers focused on Immune Cell Function and Interaction (17 papers), T-cell and B-cell Immunology (16 papers) and Immunotherapy and Immune Responses (11 papers). Urs Karrer collaborates with scholars based in Switzerland, Austria and United Kingdom. Urs Karrer's co-authors include Rolf M. Zinkernagel, Hans Hengartner, Annette Oxenius, Paul Klenerman, Adrian F. Ochsenbein, Bernhard Odermatt, Marcus Pericin, Sophie Sierro, Burkhard Ludewig and Rodney E. Phillips and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and The Journal of Experimental Medicine.

In The Last Decade

Urs Karrer

45 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Urs Karrer Switzerland 24 2.0k 777 633 462 403 48 3.0k
Justin J. Taylor United States 28 3.3k 1.6× 624 0.8× 551 0.9× 497 1.1× 642 1.6× 61 4.5k
Danelle S. Eto United States 19 3.2k 1.6× 855 1.1× 525 0.8× 307 0.7× 635 1.6× 20 4.5k
Elina I. Zúñiga United States 30 3.3k 1.6× 783 1.0× 643 1.0× 651 1.4× 803 2.0× 69 4.4k
Magdalena Tary‐Lehmann United States 37 2.9k 1.4× 798 1.0× 487 0.8× 603 1.3× 628 1.6× 81 4.6k
Melanie M. Brinkmann Germany 28 2.1k 1.0× 1.1k 1.5× 679 1.1× 448 1.0× 864 2.1× 56 3.6k
Jason K. Whitmire United States 43 4.0k 1.9× 954 1.2× 664 1.0× 778 1.7× 907 2.3× 77 5.6k
Francis R. Carbone Australia 34 4.6k 2.3× 758 1.0× 694 1.1× 267 0.6× 863 2.1× 52 5.4k
Haina Shin United States 19 3.5k 1.7× 847 1.1× 1.6k 2.5× 363 0.8× 432 1.1× 28 4.5k
Marion Pepper United States 35 3.8k 1.9× 675 0.9× 661 1.0× 637 1.4× 921 2.3× 71 5.3k
Qibin Leng China 28 989 0.5× 388 0.5× 394 0.6× 534 1.2× 766 1.9× 64 2.3k

Countries citing papers authored by Urs Karrer

Since Specialization
Citations

This map shows the geographic impact of Urs Karrer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Urs Karrer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Urs Karrer more than expected).

Fields of papers citing papers by Urs Karrer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Urs Karrer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Urs Karrer. The network helps show where Urs Karrer may publish in the future.

Co-authorship network of co-authors of Urs Karrer

This figure shows the co-authorship network connecting the top 25 collaborators of Urs Karrer. A scholar is included among the top collaborators of Urs Karrer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Urs Karrer. Urs Karrer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Scheier, Thomas, Christian Rüegg, Urs Karrer, et al.. (2021). Universal Admission Screening for SARS-CoV-2 Infections among Hospitalized Patients, Switzerland, 2020. Emerging infectious diseases. 27(2). 404–410. 18 indexed citations
3.
Wittwer, Matthias, Paola Pilo, Sebastian M. Gygli, et al.. (2018). Population Genomics of Francisella tularensis subsp. holarctica and its Implication on the Eco-Epidemiology of Tularemia in Switzerland. Frontiers in Cellular and Infection Microbiology. 8. 89–89. 24 indexed citations
4.
Tchang, Vincent S., Michael Stieß, Kerstin Siegmund, Urs Karrer, & Jean Pieters. (2016). Role for coronin 1 in mouse NK cell function. Immunobiology. 222(2). 291–300. 3 indexed citations
5.
Karrer, Urs & David Nadal. (2014). Epstein-Barr Virus und infektiöse Mononukleose. Swiss Medical Forum ‒ Schweizerisches Medizin-Forum. 14(11). 1 indexed citations
6.
Stiasny, Karin, Georgios Tsouchnikas, Urs Karrer, et al.. (2013). Dissection of Antibody Specificities Induced by Yellow Fever Vaccination. PLoS Pathogens. 9(6). e1003458–e1003458. 59 indexed citations
7.
Stiasny, Karin, et al.. (2012). Quantitative determination of IgM antibodies reduces the pitfalls in the serodiagnosis of tick-borne encephalitis. Journal of Clinical Virology. 54(2). 115–120. 35 indexed citations
8.
Tchang, Vincent S., et al.. (2012). Immune Senescence: Relative Contributions of Age and Cytomegalovirus Infection. PLoS Pathogens. 8(8). e1002850–e1002850. 72 indexed citations
9.
Probst, Paul, et al.. (2010). Die Brucellose als Differentialdiagnose zum Hodentumor. Der Urologe. 50(1). 71–73. 3 indexed citations
10.
Clifford, Gary M., Martin Rickenbach, M. Lise, et al.. (2009). Hodgkin lymphoma in the Swiss HIV Cohort Study. Blood. 113(23). 5737–5742. 76 indexed citations
11.
Vogt, Peter, et al.. (2009). Disseminated Toxoplasmosis in a Patient with Non-Hodgkin Lymphoma. Infection. 37(6). 551–554. 14 indexed citations
12.
Karrer, Urs, et al.. (2009). Cytomegalovirus and immune senescence: Culprit or innocent bystander?. Experimental Gerontology. 44(11). 689–694. 12 indexed citations
13.
Agnellini, Paola, Petra Wolint, Manuela Rehr, et al.. (2007). Impaired NFAT nuclear translocation results in split exhaustion of virus-specific CD8 + T cell functions during chronic viral infection. Proceedings of the National Academy of Sciences. 104(11). 4565–4570. 115 indexed citations
14.
Karrer, Urs, Sophie Sierro, Markus Wagner, et al.. (2003). Memory Inflation: Continuous Accumulation of Antiviral CD8+ T Cells Over Time. The Journal of Immunology. 170(4). 2022–2029. 350 indexed citations
15.
Karrer, Urs, Sophie Sierro, Annette Oxenius, et al.. (2003). Memory Inflation: Continous Accumulation of Antiviral CD8+ T Cells Over Time. The Journal of Immunology. 171(7). 3895–3895. 6 indexed citations
16.
Lucas, Michaela, Urs Karrer, Andrew Lucas, & Paul Klenerman. (2001). Viral escape mechanisms – escapology taught by viruses. International Journal of Experimental Pathology. 82(5). 269–286. 78 indexed citations
17.
Ochsenbein, Adrian F., Sophie Sierro, Bernhard Odermatt, et al.. (2001). Roles of tumour localization, second signals and cross priming in cytotoxic T-cell induction. Nature. 411(6841). 1058–1064. 426 indexed citations
18.
Karrer, Urs, Constantino López-Macı́as, Annette Oxenius, et al.. (2000). Antiviral B Cell Memory in the Absence of Mature Follicular Dendritic Cell Networks and Classical Germinal Centers in TNFR1−/− Mice. The Journal of Immunology. 164(2). 768–778. 40 indexed citations
19.
Karrer, Urs, Alana Althage, B Odermatt, Hans Hengartner, & Rolf M. Zinkernagel. (2000). Immunodeficiency of alymphoplasia mice (aly/aly)in vivo: structural defect of secondary lymphoid organs and functional B cell defect. European Journal of Immunology. 30(10). 2799–2807. 47 indexed citations
20.
Faßbender, Klaus, B. Gerber, Urs Karrer, et al.. (1993). Glycosylation of acute phase proteins and interleukins following hip arthroplasty: Inflammation parameters studied in 10 patients. Acta Orthopaedica Scandinavica. 64(2). 216–220. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026